[ad_1]
“No, we do not plan, because this vaccine is not registered in any country of the European Union. The European Medicines Agency (EMA) has not evaluated it, as have the comments here, “the prime minister told reporters on Friday.
The head of European Union diplomacy, Joseph Borrell, on Friday expressed his hope that the COVID-19 vaccine developed in Russia will be used throughout the community in the near future.
Borrell, who was visiting Moscow, said the Sputnik V vaccine was “good news for all mankind.”
When asked if Lithuania would buy the vaccine if it were approved in the European Union, the prime minister said she could not follow the assumptions.
“The EEA decides which vaccine should be approved, not Mr Borrell. There will be no more comment than I did on this issue, because ‘Sputnik’ is definitely not the vaccine that we have included in our vaccine portfolio,” said I. Šimonytė.
The vaccine was approved by the Russian government in August and many foreign countries were interested in acquiring it.
According to Russian scientists, the vaccine appears to be safe and effective against COVID-19, according to preliminary results of a special study published in the British medical journal The Lancet. According to the researchers, after testing the vaccine with about 20 thousand. volunteers in Russia, the vaccine was found to be 91 percent effective.
The EU has signed six treaties for more than 2 billion euros. Vaccine doses from different manufacturers, but so far only three of them have been approved in the Community and the vaccine supply is stagnant due to production delays.
The European Medicines Agency has not yet received a request for authorization to distribute Sputnik V. This week, the agency received a request for scientific advice from vaccine developers and a meeting was held to “discuss the development plan and further cooperation. with the agency. “
[ad_2]
